Does relapse matter? Insights from new data in schizophrenia.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 41208388.
- Also identified by DOI 10.1192/bjp.2025.10470 and PMC identifier 7618425.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
It is often assumed that relapse leads to poor long-term outcomes, but new data question this in regard to symptoms, social function, quality of life and, possibly, employment. We consider this together with other impacts, risks and costs and how individual circumstances all influence decisions about antipsychotic maintenance treatment to prevent relapse.
Medical subject headings
- Schizophrenia
- Antipsychotic Agents